Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma
Authors:
- Christopher R. JonesCJChristopher R. Jones
- Monique N. Vanoli-StorzMVMonique N. Vanoli-Storz
- Sabine KohlerSKSabine Kohler
- Sunil ReddySRSunil Reddy
- Ranjana AdvaniRARanjana Advani
- Richard T. HoppeRHRichard T. Hoppe
- Youn H. KimYKYoun H. Kim
Open Access
- 1 June 2009
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 145 (6) , 667-674
Abstract
Primary cutaneous CD30+ lymphoproliferative disorders are the second most common group of cutaneous T-cell lymphomas (CTCLs).1Primary cutaneous anaplastic large cell lymphoma (pcALCL) represents the malignant end of this spectrum of disorders that also includes lymphomatoid papulosis (LyP) and borderline lesions. Clinically, patients with pcALCL present with solitary or localized nodules or tumors, often showing ulceration. Histologically, there are cohesive sheets of large cells with anaplastic, pleomorphic, or immunoblastic cytomorphologic characteristics and expression of CD30 by more than 75% of the tumor cells.1Keywords
This publication has 27 references indexed in Scilit:
- TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)Blood, 2007
- HIPK2, a Versatile Switchboard Regulating the Transcription Machinery and Cell DeathCell Cycle, 2007
- WHO-EORTC classification for cutaneous lymphomasBlood, 2005
- Cd30+ cutaneous lymphoproliferative disorders: The stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphomaJournal of the American Academy of Dermatology, 2003
- Specific Inhibition of Stat5a/b Promotes Apoptosis of IL-2-Responsive Primary and Tumor-Derived Lymphoid CellsThe Journal of Immunology, 2003
- A microarray-based, integrated approach to identify novel regulators of cancer drug response and apoptosisOncogene, 2002
- Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2Nature Cell Biology, 2001
- Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosisNature Cell Biology, 2001
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001
- Cluster analysis and display of genome-wide expression patternsProceedings of the National Academy of Sciences of the United States of America, 1998